Status:

WITHDRAWN

Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth

Lead Sponsor:

Atrium Innovations

Collaborating Sponsors:

Dr. Nathan Morris, MD

Genova Diagnostics

Conditions:

Small Intestinal Bacterial Overgrowth

Eligibility:

All Genders

19-84 years

Phase:

EARLY_PHASE1

Brief Summary

Study Synopsis This pilot study will determine the efficacy of a novel supplement protocol and low FODMAP diet for the treatment of small intestinal bacterial overgrowth (SIBO). The study will operat...

Detailed Description

Background Small intestinal bacterial overgrowth (SIBO) is a category of gastrointestinal infection, characterized by an increased concentration (\>100,000 CFU/mL proximal jejunal fluid) of bacteria ...

Eligibility Criteria

Inclusion

  • A positive diagnosis of SIBO, which will be defined by:
  • presentation of the aforementioned symptoms and
  • positive results of a lactulose breast test. Positive breath test results will be defined as an increase in hydrogen of 20 ppm or more and/or an increase in methane of 12 ppm or more compared to baseline by 90 minutes.

Exclusion

  • Use of prescription antibiotics or antifungals within the past 4 weeks.
  • Younger than 18 or older than 85 years of age.
  • Pregnant or breastfeeding.
  • Major drug-supplement interactions between essential medication and the proposed supplement therapy.
  • A known allergy to one or more of the ingredients in the supplement therapy.
  • Has been diagnosed and treated for SIBO within the past 6 months.
  • Has undergone a colonoscopy or barium enema within the past 4 weeks.
  • Has an allergy to lactulose. 9) Has diabetes mellitus.

Key Trial Info

Start Date :

December 7 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2019

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03420976

Start Date

December 7 2017

End Date

February 1 2019

Last Update

January 12 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Good Medicine

Oxford, Ohio, United States, 45056